ADAM33 (ADAM metallopeptidase domain 33)

2007-04-01  

Identity

HGNC
LOCATION
20p13
LOCUSID
ALIAS
C20orf153,DJ964F7.1

Other Information

Locus ID:

NCBI: 80332
MIM: 607114
HGNC: 15478
Ensembl: ENSG00000149451

Variants:

dbSNP: 80332
ClinVar: 80332
TCGA: ENSG00000149451
COSMIC: ADAM33

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000149451ENST00000350009Q9BZ11
ENSG00000149451ENST00000356518Q9BZ11
ENSG00000149451ENST00000379861A2A2L3
ENSG00000149451ENST00000617732Q08AM3
ENSG00000149451ENST00000619289Q08AM2

Expression (GTEx)

0
50
100
150
200
250
300
350
400
450
500

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
369779012023Role of ADAM33 short isoform as a tumor suppressor in the pathogenesis of thyroid cancer via oncogenic function disruption of full-length ADAM33.0
373729592023The rs16969968 Tobacco Smoking-Related Single-Nucleotide Variant Is Associated with Clinical Markers in Patients with Severe COVID-19.1
374993922023Evaluation of the association between clinical parameters and ADAM33 and ORMDL3 asthma gene single-nucleotide polymorphisms with the severity of COVID-19.1
369779012023Role of ADAM33 short isoform as a tumor suppressor in the pathogenesis of thyroid cancer via oncogenic function disruption of full-length ADAM33.0
373729592023The rs16969968 Tobacco Smoking-Related Single-Nucleotide Variant Is Associated with Clinical Markers in Patients with Severe COVID-19.1
374993922023Evaluation of the association between clinical parameters and ADAM33 and ORMDL3 asthma gene single-nucleotide polymorphisms with the severity of COVID-19.1
337403922021Signatures for chronic obstructive pulmonary disease (COPD) and asthma: a comparative genetic analysis.2
339827672021Silencing a disintegrin and metalloproteinase‑33 attenuates the proliferation of vascular smooth muscle cells via PI3K/AKT pathway: Implications in the pathogenesis of airway vascular remodeling.3
348488002021The strong correlation between ADAM33 expression and airway inflammation in chronic obstructive pulmonary disease and candidate for biomarker and treatment of COPD.11
337403922021Signatures for chronic obstructive pulmonary disease (COPD) and asthma: a comparative genetic analysis.2
339827672021Silencing a disintegrin and metalloproteinase‑33 attenuates the proliferation of vascular smooth muscle cells via PI3K/AKT pathway: Implications in the pathogenesis of airway vascular remodeling.3
348488002021The strong correlation between ADAM33 expression and airway inflammation in chronic obstructive pulmonary disease and candidate for biomarker and treatment of COPD.11
307919112019Association between ADAM33 polymorphisms and asthma risk: a systematic review and meta-analysis.12
313570202019Association between F+1 polymorphism in a disintegrin and metalloprotease 33 (ADAM33) gene and chronic obstructive pulmonary disease susceptibility: An evidence-based meta-analysis.2
314235132019Evaluation of ADAM33 gene's single nucleotide polymorphism variants against asthma and the unique pattern of inheritance in Northern and Central Punjab, Pakistan.0

Citation

Dessen P

ADAM33 (ADAM metallopeptidase domain 33)

Atlas Genet Cytogenet Oncol Haematol. 2007-04-01

Online version: http://atlasgeneticsoncology.org/gene/46871/adam33-(adam-metallopeptidase-domain-33)